Literature DB >> 28638999

Osteopontin and clusterin levels in type 2 diabetes mellitus: differential association with peripheral autonomic nerve function.

Raelene E Maser1,2, M James Lenhard3,4, Ryan T Pohlig5, P Babu Balagopal6.   

Abstract

Osteopontin (OPN) and clusterin are secreted glycoproteins potentially associated with nerve function. Sudomotor dysfunction is associated with the development of foot ulcerations. The purpose of this study was to investigate the potential relationship of OPN and clusterin with sudomotor function (i.e., autonomic nerves that control sweating) in participants with type 2 diabetes mellitus (T2DM). Sudomotor function was assessed using SUDOSCAN® which measures electrochemical skin conductance (ESC) of the hands and feet. Demographics (e.g., age, gender, race, body mass index (BMI)), HbA1c, 25-hydroxyvitamin D, creatinine, OPN, and clusterin were also determined for the participants. Fifty individuals with T2DM (age = 59±11 years; 23/27 male/female; 13 African Americans) participated in this study. Lower ESC for the hands and feet were observed in African Americans versus Caucasians/Asians (p < 0.05). No significant ESC differences were observed for good [HbA1c <7%] versus poor [HbA1c ≥7%] glycemic control. With regard to gender, ESC values were lower for the hands for females (p < 0.05). In linear regression with ESC for the hands or feet as the dependent variable, increased OPN levels, but not clusterin, were independently associated with reduced sudomotor function while adjusting for age, gender, race, BMI, and glycemic control (ESC hands model R 2 = 0.504, p < 0.001; ESC feet model R 2 = 0.534, p < 0.001). The association between OPN and reduced sudomotor function found in our study warrants further investigation to delineate the underlying mechanisms and determine if OPN is neuroprotective, involved in the pathogenesis of sudomotor dysfunction, or simply a bystander.

Entities:  

Keywords:  Clusterin; Osteopontin; Sudomotor function; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2017        PMID: 28638999      PMCID: PMC5709198          DOI: 10.1007/s10072-017-3019-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  31 in total

Review 1.  Clusterin is a secreted mammalian chaperone.

Authors:  M R Wilson; S B Easterbrook-Smith
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

Review 2.  Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms.

Authors:  P Sytze Van Dam; Mary A Cotter; Bert Bravenboer; Norman E Cameron
Journal:  Eur J Pharmacol       Date:  2013-07-17       Impact factor: 4.432

3.  Normative Values for Electrochemical Skin Conductances and Impact of Ethnicity on Quantitative Assessment of Sudomotor Function.

Authors:  Aaron I Vinik; A Gordon Smith; J Robinson Singleton; Brian Callaghan; Barry I Freedman; Jaakko Tuomilehto; Lyse Bordier; Bernard Bauduceau; Frederic Roche
Journal:  Diabetes Technol Ther       Date:  2016-04-08       Impact factor: 6.118

4.  Osteopontin: a novel axon-regulated Schwann cell gene.

Authors:  Sebastian Jander; Simona Bussini; Eva Neuen-Jacob; Frank Bosse; Til Menge; Hans-Werner Müller; Guido Stoll
Journal:  J Neurosci Res       Date:  2002-01-15       Impact factor: 4.164

Review 5.  Glucose control and diabetic neuropathy: lessons from recent large clinical trials.

Authors:  Lynn Ang; Mamta Jaiswal; Catherine Martin; Rodica Pop-Busui
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 6.  The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases.

Authors:  S Park; K W Mathis; I K Lee
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

7.  Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function.

Authors:  Raelene E Maser; M James Lenhard; Ryan T Pohlig; P Babu Balagopal
Journal:  J Diabetes Complications       Date:  2015-12-17       Impact factor: 2.852

8.  Quantification of sweat gland innervation: a clinical-pathologic correlation.

Authors:  Christopher H Gibbons; Ben M W Illigens; Ningshan Wang; Roy Freeman
Journal:  Neurology       Date:  2009-04-28       Impact factor: 9.910

9.  Novel roles for osteopontin and clusterin in peripheral motor and sensory axon regeneration.

Authors:  Megan C Wright; Ruifa Mi; Emmalynn Connor; Nicole Reed; Alka Vyas; Manula Alspalter; Giovanni Coppola; Daniel H Geschwind; Thomas M Brushart; Ahmet Höke
Journal:  J Neurosci       Date:  2014-01-29       Impact factor: 6.167

Review 10.  The diabetic foot: from art to science. The 18th Camillo Golgi lecture.

Authors:  A J M Boulton
Journal:  Diabetologia       Date:  2004-07-28       Impact factor: 10.122

View more
  2 in total

1.  Efficacy and tolerability of DPP4 inhibitor, teneligliptin, on autonomic and peripheral neuropathy in type 2 diabetes: an open label, pilot study.

Authors:  Ashit Syngle; Simran Chahal; Kanchan Vohra
Journal:  Neurol Sci       Date:  2020-08-15       Impact factor: 3.307

2.  Determinant of Osteopontin Levels in Microvascular Complications in Patients with Diabetes.

Authors:  Shaik Sarfaraz Nawaz; Khalid Siddiqui; Muhammad Mujammami; Obeed Alotaibi; Saud Sulaiman Alanazi; Mohamed Rafiullah
Journal:  Int J Gen Med       Date:  2022-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.